Background: To accomplish ‘Mission Twenty - Twenty’ and to achieve ‘Sustainable Development Goal 3’, now we need to focus our attention more towards neonates being transported to higher centre in this very fragile period. We planned this study to assess demographic, transport and clinical characteristics of referred neonates and to determine whether TRIPS score serves as predictor of early neonatal mortality i.e. mortality within the first seven days after admission in these babies.Methods: This cross sectional descriptive study with analytic components was carried out in a tertiary care teaching hospital. All neonates ≥1 kg, born outside of this hospital, and referred here during study period for further management were included. All the data pertaining to clinical, demographic and transport characteristics were recorded. TRIPS score was applied at admission and was related with the final outcome within first seven days of admission; expired or survived. The association between the outcome and TRIPS score was tested using chi square test or fisher’s exact test. ROC curve analysis was done to find out optimum TRIPS score to predict mortality.Results: Neonatal mortality within first 7 days after admission is related to the TRIPS rating. The score of the survivors and neonatal deaths show a significant difference which is also even reflected by its individual components (p< 0.001). For a score of >18.5, a sensitivity of 89.47% and a specificity of 91.47%; area under the curve of 0.954 was determined.Conclusions: TRIPS score is a valid predictor of early neonatal mortality. The components of TRIPS score also correlate with early neonatal death. It is important to establish measures to improve physiological stability of the newborn before, during and after the transfer in order to reduce neonatal mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.